Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...

Read the winning essay from the Young Science Writer of the Year 2024 award ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Discover the truth behind Sugar Defender reviews, revealing how this blood sugar supplement helped control my levels and ...

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

Type 1 diabetes, once known as juvenile or insulin-dependent diabetes, is a chronic health condition. In people with this ...

Cipla received approval from India's Central Drugs Standard Control Organisation to distribute and market Afrezza inhalation ...

India has the 2nd highest burden of diabetes worldwideCDSCO decision follows existing approvals in the U.S.A. and BrazilMannKind expects to ship ...

Type 1 Diabetes is a lifelong autoimmune condition that prevents a person’s pancreas from producing insulin, the hormone ...

Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in Canada.

In the United States alone, over 37 million people live with diabetes, and a significant portion of them have type 2 diabetes ...